Keros Therapeutics, Inc.
← Back to KROS Overview

Keros Therapeutics, Inc. (KROS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-4.31

Financial Fundamentals

KROSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-03-31-12.27
2019-06-30-13.50
2019-09-30-11.15
2019-12-31-16.19
2020-03-31-7.19
2020-06-30-15.08
2020-09-30-16.16
2020-12-31-35.99
2021-03-31-22.63
2021-06-30-15.85
2021-09-30-11.37
2021-12-31-48.76
2022-03-31-13.46
2022-06-30-6.98
2022-09-30-12.54
2022-12-31-11.01
2023-03-31-9.28
2023-06-30-7.91
2023-09-30-5.99
2023-12-31-7.42
2024-03-31-11.45
2024-06-30-8.75
2024-09-30-9.88
2024-12-31-3.47
2025-03-310.70
2025-06-30-4.39
2025-09-30-21.97
2025-12-31-5.92
2026-03-31-4.31

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.